Drug Screening Market Size, Share & Growth Report 2032

Drug Screening Market

Drug Screening Market By Product & Service (Equipment, Rapid Testing Devices, Consumables, And Laboratory Services), By Sample Type (Breath Sample, Urine Sample, Hair Sample, Oral Fluid Sample, And Others), By End-User (Drug Testing Laboratories, Workplace & Schools, Criminal Justice System & Law Enforcement Agencies, Drug Treatment Centers, Hospitals, Personal Users, And Pain Management Centers), And By Region - Global Industry Perspective, Comprehensive Analysis, And Forecast 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 240 Report Code: ZMR-2847 Published Date: Jun-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 7.31 Billion USD 29.52 Billion 16.89% 2023

Drug Screening Market: Industry Perspective

The global drug screening market size was worth around USD 7.31 billion in 2023 and is predicted to grow to around USD 29.52 billion by 2032 with a compound annual growth rate (CAGR) of roughly 16.89% between 2024 and 2032.

Global Drug Screening Market SizeRequest Free Sample

The report offers a valuation and analysis of the Drug Screening market on a global and regional level. The study comprehensively assesses the industry competition, restraints, revenue estimates, avenues, current & emerging trends, and industry-validated market information. The report offers historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on value (USD Billion).

Drug Screening Market: Introduction  

Drug screening is the procedure by which the potential medicines are recognized and optimized before selecting a drug candidate for further progressing to clinical tests. Moreover, it involves screening huge libraries of chemicals for specific biological activities in high throughput screening assays. Drug screening helps in analyzing & diagnosing biological samples like blood, urine, and hair, and identifies the drug presence in the patient's body. Screening of drugs is carried out to identify whether an individual has been under drug influence at a specific period or not.  Additionally, technological breakthroughs in drug screening equipment have helped the end-users acquire accurate outcomes and this has boosted the sales of drug screening devices.      

Drug Screening MarketRequest Free Sample

Drug Screening Market: Growth Dynamics

A surge in the intake of alcohol by young as well as elder persons and an increase in the use of prescribed medicines will spur the growth of the drug screening industry over the estimated timespan. Furthermore, the incessant use of narcotics as well as illegal drugs is likely to embellish the industry growth over the forecast timespan. Additionally, an increase in the competitiveness witnessed among the key players will open new horizons of growth for the market over the forecasting years.

Furthermore, the massive use of drug screening activities in railway, transport, and airline sectors is expected to boost the industry trends. Apart from this, drug screening is done at various sports events like the Olympics and World Athletics Meet to detect the drugs like steroids consumed by athletes to boost their performance. In countries like the U.S., candidates have to undergo drug screening tests after clearing their aptitude tests and before getting an employment offer from the firms. All these aforementioned factors will drive the market growth over the estimated timespan.

Drug Screening Market: Report Scope

 

Report Attributes Report Details
Report Name Drug Screening Market
Market Size in 2023 USD 7.31 Billion
Market Forecast in 2032 USD 29.52 Billion
Growth Rate CAGR of 16.89%
Number of Pages 240
Key Companies Covered Quest Diagnostics Incorporated, Shimadzu Corporation, Siemens Healthcare Diagnostics, Inc., Express Diagnostics International, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Inc., Alere, Inc., Dragerwerk AG & Co. KGAA., and others.
Segments Covered By Product & Service, By Sample Type, By End-User, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

 

Drug Screening Market: Regional Analysis

  • North America To Establish Market Dominance Over 2024-2032

The surge in the expansion of the market in the sub-continent over the estimated timespan is attributed to a surge in drug & alcohol abuse incidences along with the enforcement of strict laws in the sub-continent. Apart from this, the high presence of key players in the region will further influence the market expansion in the sub-continent over the ensuing years. Additionally, the huge allocation of funds for eliminating drug abuse and promotion of drug screening activities along with an increase in driving under the influence has prompted the growth of the drug screening industry in the region.

Drug Screening Market: Competitive Analysis

The global drug screening market is dominated by players like:

  • Quest Diagnostics Incorporated
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics, Inc.
  • Express Diagnostics International, Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific, Inc.
  • Alere, Inc.
  • Dragerwerk AG & Co. KGAA.

The global drug screening market is segmented as follows:

By Product & Service

  • Equipment
    • Chromatography Instruments
    • Immunoassay Analyzers
    • Breath Analyzers
      • Semiconductor Breathalyzers
      • Fuel Cell Breathalyzers
      • Other Devices
  • Rapid Testing Devices
    • Urine Testing Devices
      • Dip Cards
      • Urine Testing Cups
      • Cassettes
    • Oral Fluid Testing Devices
  • Consumables
  • Laboratory Services

By Sample Type

  • Breath Sample
  • Urine Sample
  • Hair Sample
  • Oral Fluid Sample
  • Others (Sweat & Blood Samples)

By End-user

  • Drug Testing Laboratories
  • Workplace & Schools
  • Hospitals
  • Criminal Justice System & Law Enforcement Agencies
  • Pain Management Centers
  • Drug Treatment Centers
  • Personal Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Drug screening is a process that analyzes a biological sample (urine, blood, hair, saliva) to detect the presence of illegal drugs, prescription medications, or other unauthorized substances.

According to a study, the global drug screening market size was worth around USD 7.31 billion in 2023 and is expected to reach USD 29.52 billion by 2032.

The global drug screening market is expected to grow at a CAGR of 16.89% during the forecast period.

North America is expected to dominate the drug screening market over the forecast period.

Leading players in the global drug screening market include Quest Diagnostics Incorporated, Shimadzu Corporation, Siemens Healthcare Diagnostics, Inc., Express Diagnostics International, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Inc., Alere, Inc., and Dragerwerk AG & Co. KGAA., among others.

The drug screening market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed